Published in Drug Law Weekly, March 16th, 2004
The data was presented at the 17th annual Practicing Physician's Approach to the Difficult Headache Patient.
GelStat Migraine is a patent pending OTC (over-the-counter) medication for acute relief from pain and associated symptoms of migraine and migraine-like headaches. It is a liquid gel provided in single dose dispensers for sublingual (under the tongue) administration. The company's drug delivery technology, known...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.